The 2025 KDIGO guidelines acknowledge the potential clinical benefit of iron supplementation in CKD patients with profound iron deficiency, based on specific ferritin and transferrin saturation thresholds [13,21,22]. The gene discussed is TF; the disease is Iron deficiency anemia.